Menlo Park, California-based biotech startup QuanDx bagged $950,000 in a recent financing round from undisclosed backers to continue developing molecular diagnostic equipment for medical laboratories.
Bio Tech
California-based Nanomix nabs $12M in financing
Nanomix Inc, a California-based nanotechnology firm that develops next generation point-of-care diagnostic tests, received $12 million in private funding from "a strategic corporate partner and existing investors."
Startup producing test-tube leather to open facility in New York
Missouri, US-based biotech startup Modern Meadow is the process of opening a facility in New York to promote lab-grown leather and in-vitro meat to fashion firms and restaurants in the area.
US-based accelerator Singularity University to launch $50M venture fund to tackle world problems
California, US-based education center and accelerator Singularity Universtity (SU) will launch a $50-million venture fund later this year for robotics, biotech, and nanotech firms formedy by SU students and faculty.
Venture capitalists believe 2014 will be great for startup firms in need of financing- report
Although there are worries about the shortfall of funding for the venture capital industry, venture capitalists are optimistic that this will continue to be a good year for firms looking to raise money, the U-T San Diego news site reported.
Latest News
TaiGen Biotechnology Company Ltd, a biotechnology firm in Taiwan, has given Russia's R-Pharm the exclusive license to develop and commercialize the anti-infective compound nemonoxacin in the Russian Federation, Turkey and the Commonwealth of Independent States.
Drugmakers from Europe are getting lured to the Boston-Cambridge area as the biotechnology boom makes it the envy of other biotechnolgy hubs in the world, Bloomberg reported.
Schaft Inc Co-Founder Takashi Kato has launched 246 Capital, a fund that seeks to invest in technologies by Japanese startups and universities not noticed by investors, Bloomberg reported.
California, US-based clinical genomic startup Omicia has raised $6.8 million in a Series A round led by Artis Ventures for the expansion of its marketing efforts and optimization of its big data offerings.
The healthcare unit of Connecticut-based conglomerate General Electric Co (GE) agreed to acquire several life-science assets from Pennsylvania-based laboratory firm Thermo Fisher Scientific Inc in a deal that totals $1.06 billion.
Infinity Group, a private equity firm based in China, announced its investment of $4.2 million in Israel-based biotechnology firm BotanoCap, a developer of green solutions for various industries.
Boston-based firm Curoverse secured $1.5 from a seed funding round to develop and commercialize its private beta technology that helps biomedical researchers in storing and analyzing human genetic data.
Crescendo Biologics was able to gather £17.5 million or $28 million from lead investor Imperial Innovations for its Series A round. Astellas Venture Management and Sofinnova Partners also participated in the financing.
CANGENE CORP CNJ.TO SAYS CREDIT SUISSE SECURITIES (CANADA), INC. IS ACTING AS FINANCIAL ADVISOR TO CANGENE
